Cargando…
Factors associated with nonresponse to ovulation induction using letrozole among women with World Health Organization group II anovulation
CONTEXT: Letrozole, a third generation aromatase inhibitor is gaining importance in ovulation induction. Some prefer to use it as a second line agent in women who fail to respond to clomifene citrate. However, our knowledge about the predictors of response to letrozole is limited. AIMS: The study wa...
Autores principales: | Palihawadana, Thilina Sanjeewa, Wijesinghe, Prasantha Sudehana, Seneviratne, Harshalal Rukka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477453/ https://www.ncbi.nlm.nih.gov/pubmed/26157297 http://dx.doi.org/10.4103/0974-1208.158598 |
Ejemplares similares
-
Childbirth Experience Questionnaire (CEQ) in the Sri Lankan setting: translation, cultural adaptation and validation into the Sinhala language
por: Patabendige, Malitha, et al.
Publicado: (2020) -
Willingness to pay for ovulation induction treatment in case of WHO II anovulation: a study using the contingent valuation method
por: Poder, Thomas G, et al.
Publicado: (2014) -
Current evidence supporting “letrozole” for ovulation induction
por: Kar, Sujata
Publicado: (2013) -
Women’s perspectives on ovulation induction with or without IUI as treatment for normogonadotrophic anovulation: a discrete choice experiment
por: Weiss, N S, et al.
Publicado: (2017) -
An atypical presentation of an ovarian lymphoma: a case report
por: Ekanayake, Chanil Deshan, et al.
Publicado: (2018)